Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant

Journal of Pathology

Volumn 194, Issue 3, 2001, Pages 358-366

  Rocha, Ana S ^a   Soares, Paula ^a   Seruca, Raquel ^a   Máximo, Valdemar ^a   Matias Guiu, Xavier ^b   Cameselle Teijeiro, José ^c   Sobrinho Simões, Manuel ^a,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d University of Porto   (Portugal)

Author keywords

Catenins; Diffuse sclerosing variant; E cadherin; Methylation; P cadherin; Papillary thyroid carcinoma; Thyroid

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CADHERIN; CATENIN; NERVE CELL ADHESION MOLECULE; P CADHERIN; PLAKOGLOBIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; DNA METHYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCLEROSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL METAPLASIA; THYROID PAPILLARY CARCINOMA;

ALPHA CATENIN; BETA CATENIN; CADHERINS; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; CELL MEMBRANE; CYTOPLASM; CYTOSKELETAL PROTEINS; DESMOPLAKINS; DNA METHYLATION; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; TRANS-ACTIVATORS;

EID: 0034938692     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.905     Document Type: Article

References (33)

1. Morphogenetic roles of classical cadherins
2. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
3. Structural basis of cell-cell adhesion by cadherins
4. Cadherins in cancer: Implications for invasion and metastasis
5. The E-cadherin/catenin complex in invasion and metastasis
6. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas
7. E-cadherin gene mutations provide clues to diffuse gastric carcinomas
8. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
9. E-cadherin germline mutations in familial gastric cancer
10. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
11. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hürthle's cell, and poorly differentiated human thyroid carcinoma
12. Cadherin cell-cell adhesion molecules in human epithelial tissues and carcinomas
13. E-cadherin: A differentiation marker in thyroid malignancies
14. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue
15. E-cadherin gene alterations are rare events in thyroid tumours
16. Immunohisto-chemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome
17. Histological typing of thyroid tumours
18. Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases
19. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases
20. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
21. An efficient salt chloroform extraction of DNA from blood and tissues
22. E-cadherin is a tumour/invasion supressor gene mutated in human lobular breast cancers
23. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
24. Alterations in classical cadherins associated with progression in ulcerative and Chron's colitis
25. Beta- and gamma-catenin expression in thyroid carcinomas
26. Dominant negative inhibition of the association between β-catenin and c-erbB-2 by N-terminally deleted β-catenin suppresses the invasion and metastasis of cancer cells
27. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion
28. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
29. Hepatocyte growth factor/scatter factor disrupts epithelial tumor cell-cell adhesion: Involvement of beta-catenin
30. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma
31. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
32. Re-expression of E-cadherin, α-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients